Oncogenic KRAS plays a key role in controlling tumor metabolism, by changing multiple metabolic pathways to give a favor to cancer cells, including the stimulation of glucose uptake, differential channeling of glucose intermediates, reprogrammed glutamine metabolism, increased autophagy, and micropinocytosis [20]. Here, KRAS is linked to neoplasm.